1. Home
  2. SRI vs CYBN Comparison

SRI vs CYBN Comparison

Compare SRI & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRI
  • CYBN
  • Stock Information
  • Founded
  • SRI 1965
  • CYBN 2019
  • Country
  • SRI United States
  • CYBN Canada
  • Employees
  • SRI N/A
  • CYBN N/A
  • Industry
  • SRI Auto Parts:O.E.M.
  • CYBN Pharmaceuticals and Biotechnology
  • Sector
  • SRI Consumer Discretionary
  • CYBN Health Care
  • Exchange
  • SRI Nasdaq
  • CYBN Nasdaq
  • Market Cap
  • SRI 210.9M
  • CYBN 176.5M
  • IPO Year
  • SRI 1997
  • CYBN N/A
  • Fundamental
  • Price
  • SRI $6.81
  • CYBN $6.07
  • Analyst Decision
  • SRI Buy
  • CYBN Strong Buy
  • Analyst Count
  • SRI 1
  • CYBN 3
  • Target Price
  • SRI $16.00
  • CYBN $85.00
  • AVG Volume (30 Days)
  • SRI 186.5K
  • CYBN 703.6K
  • Earning Date
  • SRI 10-29-2025
  • CYBN 11-12-2025
  • Dividend Yield
  • SRI N/A
  • CYBN N/A
  • EPS Growth
  • SRI N/A
  • CYBN N/A
  • EPS
  • SRI N/A
  • CYBN N/A
  • Revenue
  • SRI $877,921,000.00
  • CYBN N/A
  • Revenue This Year
  • SRI N/A
  • CYBN N/A
  • Revenue Next Year
  • SRI $7.68
  • CYBN N/A
  • P/E Ratio
  • SRI N/A
  • CYBN N/A
  • Revenue Growth
  • SRI N/A
  • CYBN N/A
  • 52 Week Low
  • SRI $3.54
  • CYBN $4.81
  • 52 Week High
  • SRI $10.33
  • CYBN $13.88
  • Technical
  • Relative Strength Index (RSI)
  • SRI 29.52
  • CYBN 45.65
  • Support Level
  • SRI $7.38
  • CYBN $5.72
  • Resistance Level
  • SRI $7.72
  • CYBN $6.63
  • Average True Range (ATR)
  • SRI 0.29
  • CYBN 0.34
  • MACD
  • SRI -0.13
  • CYBN 0.07
  • Stochastic Oscillator
  • SRI 1.98
  • CYBN 37.75

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About CYBN Cybin Inc.

Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The Company is a clinical-stage neuropsychiatric company focused on advancing therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions. The Company is developing technologies and delivery systems aimed at improving the pharmacokinetics of its proprietary molecules while retaining the therapeutic benefit. These new molecules and delivery systems are expected to be studied through clinical trials to confirm safety and efficacy.

Share on Social Networks: